Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Precision Digital Health Enters into Partnership with Datavant to Enable Real-World Data Linkages within SUMMA Platform

Precision Digital Health (PDH)  announced a strategic partnership enabling PDH to use Datavant’s data linking technology within their SUMMA platform. SUMMA is a cutting-edge Real-World Evidence (RWE) platform that enables life science companies and CROs to integrate and link patient data to support regulatory-compliant research.

Recommended AI News: Vuzix Releases Details Of Its Next Generation Smart Glasses Powered By Micro-LED And Other Advanced Technologies

This partnership will enable SUMMA to support data flows including de-identified real-world data sourced from Datavant’s open ecosystem. SUMMA now has the ability to link client data from multiple sources, including real world, clinical trials and device data. This integrated solution gives life sciences customers an off-the-shelf system to rapidly ingest, process, and analyze a patient’s longitudinal journey.

Related Posts
1 of 40,477

“The ability to seamlessly integrate de-identified real-world data enables life sciences companies to more easily analyze and understand their results,” said Jason LaBonte, Chief Strategy Officer at Datavant. “This partnership will accelerate the pace at which life science companies can ingest and analyze proprietary or third-party data, in turn expediting the clinical and commercial development process and the speed of therapies to market.”

Recommended AI News: New Global Mood Media Study Reveals Two-Thirds (67%) Of Consumers Have Returned To Non-Essential Shopping In-Store

“We are thrilled to partner with Datavant to expand these innovative solutions for our customers,” said Thomas Wells, CEO at PDH. “Complaint data linking enables our clients to better understand and analyze disparate data sources, allowing them to perform more efficient and streamlined clinical research. SUMMA, equipped with this privacy-preserving linking capability, represents a leap forward for the use of real-world data in the clinical setting.”

Recommended AI News: Atos Helps Researchers And Students To Experiment With Quantum Algorithms By Offering Free, Universal Access To MyQLM

Comments are closed, but trackbacks and pingbacks are open.